Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Dunaújváros – page 10

198 clinical trials in Dunaújváros, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Dunaújváros at a glance
198
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

198 trials in Dunaújváros

Open in trial search

Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:Astrazeneca AB

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Sjogren's syndrome

Not recruiting

Safety Study of Efgartigimod in Adults with Primary Sjögren's Syndrome

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Psoriatic arthropathy

Not recruiting

Study on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Colitis ulcerative

Not recruiting

Study on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:MORF-057
  • Sponsor:Morphic Therapeutic Inc.

Psoriatic arthropathy

Not recruiting

Study on Izokibep for Improving Symptoms in Patients with Active Psoriatic Arthritis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Izokibep
  • Sponsor:Acelyrin Inc.

Study on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:Astrazeneca AB

Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Hypertriglyceridaemia

Not recruiting

Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Study on Trilaciclib and Topotecan for Patients with Extensive Stage Small Cell Lung Cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Pharmacosmos A/S

Study on Vixarelimab for Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Vixarelimab
  • Sponsor:Genentech Inc.

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Dunaújváros

What the registry says about research in the country

01 Cardiovascular and Stroke Research

Innovative trials focusing on atherosclerotic cardiovascular disease prevention and stroke treatment, evaluating new therapeutic approaches for reducing major cardiovascular events.

  • Primary ASCVD Prevention
  • Acute Ischemic Stroke
  • High-Risk TIA Management

Studies aim to demonstrate the effectiveness of novel compounds in preventing cardiovascular complications and improving stroke outcomes.

02 Renal and Metabolic Disorders

Research examining combination therapies for chronic kidney disease with concurrent hypertension, exploring innovative treatment approaches for better patient outcomes.

  • CKD Management
  • Hypertension Control
  • Primary Biliary Cholangitis

Trials focus on evaluating new medications to slow disease progression and improve quality of life.

03 Neurological and Pain Management

Studies investigating novel treatments for episodic migraine, focusing on preventive therapies to reduce headache frequency and severity.

  • Migraine Prevention
  • Headache Management

Research aims to develop effective preventive treatments for patients suffering from recurring migraines.

04 Gastrointestinal and Inflammatory Conditions

Clinical investigations of new therapies for ulcerative colitis, examining both short-term improvement and long-term maintenance treatments.

  • Inflammatory Bowel Disease
  • UC Management
  • Long-term Disease Control

Studies evaluate novel compounds for achieving endoscopic improvement and symptomatic remission.

05 Wound Healing and Regenerative Medicine

Innovative research utilizing stem cell therapy for treating chronic venous ulcers, focusing on wound healing in difficult-to-treat cases.

  • Chronic Wound Management
  • Regenerative Medicine
  • Venous Ulcer Treatment

Trials explore advanced therapeutic approaches for non-healing wounds using cellular treatments.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.